共 18 条
- [16] Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II-defined cohort of patients with progressive multiple sclerosis: results of a 24-month double-blind placebo-controlled clinical trial and 5 years of follow-up treatment EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 (08) : 887 - 895